Paras Healthcare Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 2,14,135 shares,. Its Average Traded Price (ATP) is ₹889.20, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 120 @ ₹880.85.
Paras Healthcare has an upper circuit limit of ₹1081.65 and a lower circuit limit of ₹721.15. The total value traded stands at ₹19.04 CR, and the delivery percentage for the day is 22.19%.
The stock is currently traded with a market lot size of 1. Paras Healthcare also offers a dividend yield of 0%.
Paras Healthcare Share Price Chart
Paras Healthcare Share Key Metrics
Volume
2.14 L
Market Cap
9530.90 CR
LTQ@LTP
120@880.85
ATP
889.2
Var Margin
25 %
Circuit Range
721.15-1081.65
Delivery %
22.19 %
Value
19.04 CR
ASM/GSM
No
Market Lot
1
Paras Healthcare Resistance and Support
Pivot 901.02
Resistance
First Resistance
930.44
Second Resistance
959.47
Third Resistance
988.89
Support
First Support
871.99
Second Support
842.57
Third Support
813.54
Paras Healthcare Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-05 | Quarterly Results |
Paras Healthcare News
Paras Healthcare Ltd - 545005 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Paras Healthcare reported Q2 FY27 results with revenue rising 22.8% YoY to Rs.510.9 crore and PAT surging 3.3x YoY to Rs.40.4 crore. The company deployed Rs.375 crore from IPO proceeds towards debt repayment to strengthen its balance sheet.
Nov 05 2026 19:50:01
Paras Healthcare Ltd - 545005 - Board Meeting Outcome for Board Approved Unaudited Standalone And Consolidated Financial Results For Quarter And Half Year Ended September 30, 2026
Paras Healthcare reported its Q2 FY27 financial results, posting a cons. revenue of ₹510.9 crores, a 23% YoY growth, and a net profit of ₹40.35 crores, marking a 226% YoY increase. Additionally, the board approved the continuation of Kabir Kishin Thakur as a Non-Executive Non-Independent Director.
Nov 05 2026 19:15:23
Paras Healthcare Ltd - 545005 - Board Meeting Intimation for Considering And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2026
Paras Healthcare announced a board meeting scheduled for November 05, 2026. The board will consider and approve the financial results for the quarter ended September 30, 2026.
Nov 02 2026 19:42:25
Paras Healthcare Management
| Name | Position |
|---|---|
| Saurabh Sood | Chairman |
| Dharminder Kumar Nagar | Managing Director |
Paras Healthcare Similar Stocks
Viyash Scientific Ltd.
237.40
1.02 (0.43%)
Park Medi World Ltd.
240.01
-5.02 (2.05%)
Symbiotec Pharmalab Ltd.
1600.60
27.10 (1.72%)
Yatharth Hospital & Trauma Care Services Ltd.
1109.55
40.50 (3.79%)
Blue Jet Healthcare Ltd.
510.60
-2.35 (0.46%)
Strides Pharma Science Ltd.
982.10
-4.00 (0.41%)
Jupiter Life Line Hospitals Ltd.
289.75
-0.15 (0.05%)
Aarti Pharmalabs Ltd.
1015.90
29.15 (2.95%)
Procter & Gamble Health Ltd.
5464.50
-131.00 (2.34%)
Healthcare Global Enterprises Ltd.
575.60
7.40 (1.30%)
Paras Healthcare FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in PARASHLTH
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC